Form 8-K - Current report:
SEC Accession No. 0001193125-24-238120
Filing Date
2024-10-16
Accepted
2024-10-16 16:08:00
Documents
15
Period of Report
2024-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d850938d8k.htm   iXBRL 8-K 26442
2 EX-10.1 d850938dex101.htm EX-10.1 54330
3 EX-10.2 d850938dex102.htm EX-10.2 56712
  Complete submission text file 0001193125-24-238120.txt   289753

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crnx-20241010.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20241010_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20241010_pre.xml EX-101.PRE 10818
17 EXTRACTED XBRL INSTANCE DOCUMENT d850938d8k_htm.xml XML 3510
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 241374668
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)